Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI in Elderly Patients with Advanced Gastric Cancer
NCT00210184Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Jul 2004
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan in gastric cancer (GC), sponsored by Institut Bergonié. Primary endpoint: 2-month Response Rate. Started Jul 2004; status: completed.
02
Drugs
irinotecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00210184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210184.